Join to View Full Profile
200 1st St SWRochester, MN 55905
Phone+1 507-284-2511
Dr. Johnson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Geoffrey Johnson is a radiologist and nuclear medicine physician at the Mayo Clinic in Rochester, MN and is chair of nuclear medicine. He received his undergraduate degree in chemical engineering at MIT, his medical degree from the Mayo Clinic School of Medicine and his graduate degree in Immunology from Mayo Graduate School. He has been in practice 12 years. He specializes in nuclear cardiology, nuclear medicine, thoracic imaging, and nuclear radiology and is experienced in nuclear therapy, amyloidosis, positron emission tomography (PET/CT and PET/MR) and lung neoplasms. He has a joint appointment in Immunology.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Nuclear Radiology, 2010 - 2011- Mayo Clinic College of Medicine and Science (Rochester)Residency, Radiology-Diagnostic, 2006 - 2010
- Mayo Clinic College of Medicine and Science (Rochester)Internship, Internal Medicine, 2005 - 2006
- Mayo Clinic College of MedicineClass of 2005
- Mayo Clinic College of Medicine and Science (Rochester)Post-Doctoral Fellowship, Surgery, 2002 - 2003
Certifications & Licensure
AZ State Medical License 2013 - 2027
IA State Medical License 2009 - 2026
MN State Medical License 2006 - 2026
FL State Medical License 2013 - 2025
SD State Medical License Active through 2025
WI State Medical License 2010 - 2025
NE State Medical License 2010 - 2018
American Board of Nuclear Medicine Nuclear Medicine
American Board of Radiology Diagnostic Radiology- American Board of Radiology Nuclear Radiology
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Centricity Enterprise (CE), GE Healthcare, 2013-2017
- CMS Meaningful Use Stage 1 Certification Centricity Patient Online, GE Healthcare, 2013-2017
- CMS Meaningful Use Stage 2 Certification Mayo Clinic Electronic Notes, Mayo Clinic, 2013-2017
Clinical Trials
Publications & Presentations
PubMed
- CCholine-PET/CT as a Localization Standard for Reoperative Primary Hyperparathyroidism.Peter Hopmann, Sarah Lund, Trenton Foster, Benzon Dy, Travis McKenzie
The American Surgeon. 2026-01-05 - Outcomes of Peptide Receptor Radionuclide Therapy withLu-DOTATATE in Patients with Metastatic Pheochromocytoma and Paraganglioma.Gokce Belge Bilgin, Brian J Burkett, Cem Bilgin, Jolanta M Durski, Ann T Packard
Journal of Nuclear Medicine. 2026-01-02 - Diagnostic Performance and Interpreter Experience of 1-Hour Versus 3-HourTc-HMDP Cardiac Amyloid Radionuclide Imaging: A Prospective, Blinded Comparison.Gregorio Tersalvi, Patricia Carey, Armin Garmany, Christopher G Scott, Jun Zhang
Circulation. Cardiovascular Imaging. 2026-01-01
Journal Articles
- Rheumatoid Pulmonary Nodules: Clinical and Imaging Features Compared with MalignancyMisbah Baqir, Paul A Decker, Geoffrey B Johnson, Jay H Ryu, European Radiology
Authored Content
- Borderline Resectable and Locally Advanced Pancreas Cancer: FDG PET/MRI and CT Tumor Metrics for Assessment of Neoadjuvant Therapy Pathologic Response and Prediction of SurvivalOctober 2020
Press Mentions
Clinical Trials: A Significant Part of Cancer CareMay 1st, 2025- Radiopharmaceutical Therapy May Offer Benefit in Patients with Refractory MeningiomaOctober 7th, 2024
- Extending Survival in Meningioma Patients with Innovative Radiopharmaceutical TherapySeptember 28th, 2024
Professional Memberships
- Member
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
